Conditions: Diabetes, Type 1 Diabetes, Type 2 Foot Ulcer, Diabetic
Keywords: Adult
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 2
Healthy volunteers: no

Brief summary:
The purpose of this study is to investigate the relationship of hemoglobin A1c in diabetic wound healing. Additionally, a comparison of two wound dressings, AmeriGel® (Amerx Health Care Corp., Clearwater, FL) and Bacitracin, with and without vitamin C supplementation, will be done to evaluate impact on time to wound closure.

Detailed description:
This is a prospective randomized controlled study evaluating the relationship of hemoglobin A1c in diabetic wound healing. Length of time for wound closure will be compared using four treatment options.

Arms:
arm 1: Bacitracin wound care dressing alone arm 2: Bacitracin wound care dressing with Vitamin C supplementation arm 3: AmeriGel® wound care dressing alone arm 4: AmeriGel® wound care dressing with Vitamin C supplementation

Interventions: intervention 1: Bacitracin intervention 2: AmeriGel® intervention 3: Vitamin C
Intervention descriptions: intervention 1: Participants will be treated with Bacitracin to their wound until 100% wound healing, which may take up to 6 months to achieve. intervention 2: Participants will be treated with AmeriGel® to their wound until 100% wound healing, which may take up to 6 months to achieve. intervention 3: Participants will be treated with Vitamin C supplements 1000 mg daily until 100% wound healing, which may take up to 6 months to achieve

Protocol document: